2025. CARDIOVASCULAR RISK PROFILES OF MONOTHERAPY VS. COMBINATION THERAPY IN TYPE 2 DIABETES. Review Journal of Neurological & Medical Sciences Review. 3, 7 (Nov. 2025), 140–147. DOI:https://doi.org/10.63075/7swvcz45.